In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans -resveratrol
Source abstract
Abstract
To develop an optimized supersaturable self-nanoemulsifying drug delivery system (S-SNEDDS) in order to improve the oral bioavailability of trans-resveratrol (t-RVT), together with surmounting poor aqueous solubility, enterohepatic recirculation and controlling drug precipitation, by employing a precipitation inhibitor (PPI) that is, hydroxypropyl methylcellulose (HPMC). The long-term stability of a previously reported formulation optimized long chain triglycerides (OPT LCT-SNEDDS), consisting of Lauroglycol FCC and Transcutol P, indicated rapid precipitation of trans-resveratrol. Following incorporation of the selected PPI, the precipitates were differentiated using the X-ray diffraction (XRD) technique. An in vitro supersaturation test was carried out for the S-SNEDDS formulation. The S-SNEDDS formulation was appraised for pharmacokinetic and in situ perfusion studies. In vitro dilution of the S-SNEDDS formulation resulted in the formation of a nanoemulsion, followed by a slow precipitation of t-RVT in the S-SNEDDS formulation vis-à-vis SNEDDS formulated with OPT-LCT, where it undergoes rapid precipitation, yielding a low t-RVT concentration. The pharmacokinetic study indicated that the AUC(0-8h) of the S-SNEDDS formulation increased by nearly 1.33-fold in the presence of HPMC vis-à-vis the OPT LCT-SNEDDS, at a drug dose of 20 mg/kg. The in situ perfusion parameters, viz., fraction absorbed and effective permeability, demonstrated significant improvement in the rate and extent of absorption from the S-SNEDDS formulation. This case demonstrates that the supersaturatable approach is effective in delivering and in improving the oral bioavailability of t-RVT.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Toxin Mechanisms and Immunotoxins · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Faculty of Pharmacy, Al-Ameen College of Pharmacy
References (24)
Show source-provided references
1. 10.1002/mnfr.20080017710.1002/mnfr.200800177 ↗
2. 10.1016/j.jconrel.2011.09.08310.1016/j.jconrel.2011.09.083 ↗
3. 10.1016/j.ejpb.2013.10.01510.1016/j.ejpb.2013.10.015 ↗
4. 10.1016/j.ejpb.2009.03.00110.1016/j.ejpb.2009.03.001 ↗
5. 10.1517/17425247.2014.87788510.1517/17425247.2014.877885 ↗
6. 10.1002/jps.2165010.1002/jps.21650 ↗
7. 10.2147/IJN.S3318610.2147/IJN.S33186 ↗
8. 10.1517/17425247.3.1.9710.1517/17425247.3.1.97 ↗
9. 10.1002/jps.2145110.1002/jps.21451 ↗
10. 10.1166/jnn.2006.42010.1166/jnn.2006.420 ↗
11. 10.1016/S0022-5193(88)80123-110.1016/S0022-5193(88)80123-1 ↗
12. 10.1016/j.jfoodeng.2011.07.03410.1016/j.jfoodeng.2011.07.034 ↗
13. 10.1124/jpet.102.03334010.1124/jpet.102.033340 ↗
14. 10.1016/j.polymer.2005.07.01610.1016/j.polymer.2005.07.016 ↗
15. 10.1016/S0169-409X(01)00151-X10.1016/S0169-409X(01)00151-X ↗
16. 10.1517/17425247.2014.89058810.1517/17425247.2014.890588 ↗
17. 10.3109/10717544.2014.88561610.3109/10717544.2014.885616 ↗
18. 10.1016/j.jconrel.2014.09.00210.1016/j.jconrel.2014.09.002 ↗
19. 10.1007/s40005-013-0105-010.1007/s40005-013-0105-0 ↗
20. 10.1016/j.cis.2008.10.00510.1016/j.cis.2008.10.005 ↗
21. 10.1016/j.jconrel.2012.02.02710.1016/j.jconrel.2012.02.027 ↗
22. 10.1039/c3ra41972j10.1039/c3ra41972j ↗
23. 10.1016/j.colsurfa.2011.12.02510.1016/j.colsurfa.2011.12.025 ↗
24. 10.1002/jps.2335810.1002/jps.23358 ↗